… are sometimes necessary due to various pregnancy-induced … drug monitoring (TDM) in
pregnant women have not been specifically studied. Clinical pharmacokinetic studies in pregnant …

… used during pregnancy and is well tolerated [57], thus it has a role in the management of
pregnant patients with HIV infection [59]. NFV is classified as FDA pregnancy category B [34]. …

… drug monitoring (TDM) during pregnancy has been suggested for select medications to assist
in the management of pregnant patients. … pharmacodynamics during pregnancy and their …

… , distribution, metabolism, and elimination of drugs. Although there is a potential need to …
drugs in pregnant patients, therapeutic drug monitoring is not well established for various drug …

… recommends that therapeutic drug monitoring of lamotrigine should be considered in
pregnant women with epilepsy.20 Other authors have recommended such monitoring for women …

… during pregnancy is often complicated by pregnancy-related … drug monitoring (TDM), and
make clinical recommendations. … drug monitoring, in combination with clinical monitoring, is …

… therapeutic drug monitoring is justified during pregnancy for … concerning pharmacokinetics
during pregnancy. Given the … of these drugs are not expected to decline during pregnancy as …

… tions for choosing specific drugs to minimize fetal drug exposure while achieving therapeutic
objectives in the pregnant patient. In this regard, the role of therapeutic drug monitoring, in …

… of antiepileptic drugs in women during pregnancy. In addition, we … and therapeutic drug
monitoring of antiepileptic drugs. We … antiepileptic drugs and seizure frequency during pregnancy …

… of drug handling by the pregnant woman. Therapeutic drug monitoring during pregnancy aims
… taking into account relevant pregnancy-induced changes in drug disposition. Therefore, to …